Literature DB >> 7042312

Evaluation of adenosine or related nucleosides as physiological regulators of lipolysis in adipose tissue.

Y Shechter.   

Abstract

The removal of extracellular, endogenously produced adenosine in isolated rat adipocytes by treatment with adenosine deaminase enhanced their responsiveness to various lipolytic agents, i.e. the response to catecholamines, glucagon, LH, TSH, and cholera toxin was elicited at concentrations that were 10-500 times lower than those required for the stimulation of lipolysis in untreated cells in vitro. The removal of adenosine from intact fat cells largely potentiated the isoproterenol-stimulated increase in cAmP level. However, a similar treatment of undissociated segments of adipose tissue failed to influence further the response to isoproterenol. These results strongly suggest that in the intact adipose tissue, adenosine and related nucleosides are absent and do not function as modulators of adenylate cyclase or lipolysis. Under these circumstances the estimated "low" physiological concentrations of the neurotransmitters in the adipose tissue are able to modulate lipid mobilization. Previous studies have shown that insulin failed to inhibit lipolysis, induced by micromolar norepinephrine concentrations, in adenosine-free adipocytes. The present study demonstrates that at physiological catecholamine concentrations, insulin is a potent antilipolytic agent.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042312     DOI: 10.1210/endo-110-5-1579

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Regulation of lipolysis during pregnancy and lactation in sheep. Response to noradrenaline and adenosine.

Authors:  R G Vernon; E Finley
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

2.  Insulin-like effects of tungstate and molybdate: mediation through insulin receptor independent pathways.

Authors:  J Li; G Elberg; J Libman; A Shanzer; D Cefel; Y Shechter
Journal:  Endocrine       Date:  1995-09       Impact factor: 3.633

3.  Trifluoperazine inhibits insulin action on glucose metabolism in fat cells without affecting inhibition of lipolysis.

Authors:  Y Shechter
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

4.  Changes in the anti-lipolytic action and binding to plasma membranes of N6-L-phenylisopropyladenosine in adipocytes from starved and hypothyroid rats.

Authors:  P Chohan; C Carpenter; E D Saggerson
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

5.  Inhibition of insulin-dependent lipogenesis and anti-lipolysis by protein tyrosine kinase inhibitors.

Authors:  Y Shechter; P Yaish; M Chorev; C Gilon; S Braun; A Levitzki
Journal:  EMBO J       Date:  1989-06       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.